• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Ampersand Capital Partners

edit

Ampersand is a middle market private equity firm focused on investments in two core sectors: Healthcare and Industrial.

Recent Milestones

edit

• 
  Ampersand Capital Partners invested in NDC. (4/28/11)
  Posted 4/27/11 at 7:53pm via dowjones.com
• 
  Ampersand Capital Partners invested in Nitinol Devices & Components. (4/26/11)
  Posted 4/27/11 at 7:55pm via nitinol.com
• 
  Ampersand Capital Partners invested in Blue Sky Biotech. (3/4/11)
  Posted 3/4/11 at 9:18pm via prweb.com
• 
  Ampersand Capital Partners invested in FirstRain. (3/1/10)
  Posted 3/1/10 at 12:25pm via sec.gov
• 
  Ampersand Capital Partners invested in FirstRain. (1/14/08)
  Posted 1/20/09 at 1:05pm via venturebeat.com
• 
  Ampersand Capital Partners invested in Cequent Pharmaceuticals. (6/18/07)
  Posted 11/12/09 at 5:23pm via cequentpharma.com
• 
  Ampersand Capital Partners invested in FirstRain. (4/27/06)
  Posted 3/25/10 at 10:51pm
• 
  Ampersand Capital Partners invested in Endeca. (6/1/04)
  Posted 1/30/08 at 3:45am via allbusiness.com
• 
  Ampersand Capital Partners invested in Endeca. (11/1/01)
  Posted 1/30/08 at 3:54am via news.com

Investments

Videos

Sources

1. Nitinol Devices Raises $20M From Ampersand (fis.dowjones.com) [edit]
2. NDC Raises Growth Capital from Ampersand (nitinol.com) [edit]
3. Blue Sky Biotech Announces New Investment with Ampersand Ventures (prweb.com) [edit]
4. SEC D (sec.gov) [edit]
5. FirstRain raises $13.6M for investment research (venturebeat.com) [edit]
6. Cequent Pharmaceuticals (cequentpharma.com) [edit]
7. EDGAR [edit]
8. allbusiness.com [edit]
9. news.com [edit]